We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sinovac Biotech Ltd. (AMEX:SVA), a leading Chinese biotechnology company in vaccine development and marketing, has announced that the State Food and Drug Administration (SFDA) issued a GMP (Good Manufacturing Practices) certificate for Sinovac's proprietary influenza flu vaccine, AnfluTM.
Zimbabwe's economic crisis, which has seen severe food and fuel shortages and spiralling inflation, is causing dramatic increases in the price of HIV/AIDS drugs, leaving many sufferers unable to afford treatment.
The Australian Competition and Consumer Commission said today it would not oppose the proposed merger between Arrow Pharmaceuticals Limited (AWP) and Sigma Company Limited (SIG), the watchdog's chairman, Mr Graeme Samuel, said today.
Indian drug maker Glenmark Pharmaceuticals Ltd said on Wednesday its Swiss subsidiary had acquired Servycal SA, a drug marketing firm in Argentina with expected annual revenue of $4 million.
Torrent Pharmaceuticals (Q, N,C,F)* Ltds audited results for the quarter ended September 30, 2005 are as follows: The company has posted 6.40 per cent increase in net profit to Rs 22.60 crore for the quarter ended September 30, 2005 as compared to Rs 21.24 crore for the quarter ended September 30, 2004.
CV Therapeutics Inc., a developer of drugs to treat heart disease, said Tuesday that European regulators demanded further trials for its experimental drug to treat chronic angina -- a condition in which the heart muscle does not get enough blood -- before they will consider approving the therapy.
Abbott Laboratories will pay more than $300 million to settle a dispute with U.K. biotechnology company Cambridge Antibody Technology Group Plc over the Humira arthritis treatment.